Evidence map›Paper›PMID 31891452›Full record

ReviewJournal of clinical hypertension (Greenwich, Conn.)2020

Highlights of the 2019 Japanese Society of Hypertension Guidelines and perspectives on the management of Asian hypertensive patients.

Satoshi Hoshide, Kazuomi Kario, Naoko Tomitani, Tomoyuki Kabutoya, Yook-Chin Chia, Sungha Park, Jinho Shin, Yuda Turana, Jam Chin Tay, Peera Buranakitjaroen and 13 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of clinical hypertension (Greenwich, Conn.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Lifestyle- and comorbidity-related factors for the prescription of proton pump inhibitors afterJGH open : an open access journal of gastroenterology and hepatology · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The HOPE Asia Network activity for "zero" cardiovascular events in Asia: Overview 2020.Journal of clinical hypertension (Greenwich, Conn.) · 2020
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 18 institutions in 12 countries.

Satoshi HoshideDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan.ORCID 0000-0001-7541-5751
Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan.ORCID 0000-0002-8251-4480
Naoko TomitaniDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan.
Tomoyuki KabutoyaDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan.
Yook-Chin ChiaDepartment of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia.ORCID 0000-0003-1995-0359
Sungha ParkDivision of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea.
Jinho ShinFaculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea.ORCID 0000-0001-6706-6504
Yuda TuranaDepartment of Neurology, Faculty of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.ORCID 0000-0003-4527-0285
Jam Chin TayDepartment of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore.
Peera BuranakitjaroenDepartment of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Chen-Huan ChenDepartment of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.ORCID 0000-0002-9262-0287
Jennifer NailesUniversity of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines.
Huynh Van MinhCardiac Center, University Hospital, University of Medicine and Pharmacy, Hue University, Hue, Vietnam.
Saulat SiddiqueFatima Memorial Hospital, Lahore, Pakistan.ORCID 0000-0003-1294-0430
Jorge SisonDepartment of Medicine, Medical Center Manila, Manila, Philippines.
Arieska Ann SoenartaDepartment Cardiology and Vascular Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia.
Guru Prasad SogunuruMIOT International Hospital, Chennai, India.
Apichard SukonthasarnMedicine Department, Bangkok Hospital Chiang Mai, Chiang Mai, Thailand.
Boon Wee TeoDivision of Nephrology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.ORCID 0000-0002-4911-8507
Narsingh VermaDepartment of Physiology, Faculty of Medicine, King George's Medical University, Lucknow, India.
Yuqing ZhangDivisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Tzung-Dau WangDivision of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan.ORCID 0000-0002-7180-3607
Ji-Guang WangDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-8511-1524
Jichi Medical University · JPAtma Jaya Catholic University of Indonesia · IDBangkok Hospital · THChinese Academy of Medical Sciences & Peking Union Medical College · CNHanyang University Medical Center · KRHue University · VNKing George's Medical University · INMadras Institute of Orthopaedics and Traumatology · INNational Taiwan University Hospital · TWNational University of Singapore · SGNational Yang Ming Chiao Tung University · TWPelita Harapan University · IDRuijin Hospital · CNSiriraj Hospital · THTan Tock Seng Hospital · SGUniversity of Malaya · MYUniversity of the East Ramon Magsaysay Memorial Medical Center · PHYonsei University Health System · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlike other international guidelines but in accord with the earlier Japanese Society of Hypertension (JSH) guidelines, the 2019 JSH guidelines ("JSH 2019") continue to emphasize the importance of out-of-office blood pressure (BP) measurements obtained with a home BP device. Another unique characteristic of JSH 2019 is that it sets clinical questions about the management of hypertension that are based on systematic reviews of updated evidence. JSH 2019 states that individuals with office BP < 140/90 mm Hg do not have normal BP. The final decisions regarding the diagnosis and treatment of hypertension should be performed based on out-of-office BP values together with office BP measurements. For hypertensive adults with comorbidities, the office BP goal is usually <130/80 mm Hg and the home BP goal is <125/75 mm Hg. Recommendations of JSH 2019 would be valuable for not only Japanese hypertensive patients but also Asian hypertensive patients, who share the same features including higher incidence of stroke compared with that of myocardial infarction and a steeper blood pressure-vascular event relationship.

Indexed as

HypertensionAdultAntihypertensive AgentsBlood PressureBlood Pressure DeterminationHumansJapanSphygmomanometersAntihypertensive Agentselderly populationguidelinehome blood pressurehypertension

Identifiers

PMID31891452
PMCPMC8030065
OpenAlexW2998667254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.